Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 283

1.

Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial.

Chawarski MC, Mazlan M, Schottenfeld RS.

Drug Alcohol Depend. 2008 Apr 1;94(1-3):281-4. doi: 10.1016/j.drugalcdep.2007.11.008. Epub 2007 Dec 27.

PMID:
18164145
2.

A trial of integrated buprenorphine/naloxone and HIV clinical care.

Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, O'Connor PG, Schottenfeld RS, Fiellin DA.

Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S184-90.

PMID:
17109305
3.

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.

Fiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O'Connor PG, Schottenfeld RS.

N Engl J Med. 2006 Jul 27;355(4):365-74.

4.

Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.

Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.

Arch Gen Psychiatry. 2005 Oct;62(10):1157-64.

PMID:
16203961
5.

Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: a pilot randomized clinical trial.

Chawarski MC, Zhou W, Schottenfeld RS.

Drug Alcohol Depend. 2011 Jun 1;115(3):237-9. doi: 10.1016/j.drugalcdep.2010.09.024. Epub 2010 Dec 14.

6.

A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine.

Gross A, Marsch LA, Badger GJ, Bickel WK.

Exp Clin Psychopharmacol. 2006 May;14(2):148-56.

PMID:
16756418
7.

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.

Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL.

Drug Alcohol Depend. 2003 Apr 1;69(3):263-72.

PMID:
12633912
8.

Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.

Oliveto AH, Feingold A, Schottenfeld R, Jatlow P, Kosten TR.

Arch Gen Psychiatry. 1999 Sep;56(9):812-20.

PMID:
12884887
9.

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

O'Connor PG, Oliveto AH, Shi JM, Triffleman EG, Carroll KM, Kosten TR, Rounsaville BJ, Pakes JA, Schottenfeld RS.

Am J Med. 1998 Aug;105(2):100-5.

PMID:
9727815
10.

Thrice-weekly versus daily buprenorphine maintenance.

Schottenfeld RS, Pakes J, O'Connor P, Chawarski M, Oliveto A, Kosten TR.

Biol Psychiatry. 2000 Jun 15;47(12):1072-9.

PMID:
10862807
11.

Treatment of heroin dependence with buprenorphine in primary care.

Fiellin DA, Pantalon MV, Pakes JP, O'Connor PG, Chawarski M, Schottenfeld RS.

Am J Drug Alcohol Abuse. 2002;28(2):231-41.

PMID:
12014814
12.

A pilot study of primary-care-based buprenorphine maintenance for heroin dependence.

O'Connor PG, Oliveto AH, Shi JM, Triffleman E, Carroll KM, Kosten TR, Rounsaville BJ.

Am J Drug Alcohol Abuse. 1996 Nov;22(4):523-31.

PMID:
8911590
13.

Double-blind randomized trial of buprenorphine and methadone in opiate dependence.

Petitjean S, Stohler R, D├ęglon JJ, Livoti S, Waldvogel D, Uehlinger C, Ladewig D.

Drug Alcohol Depend. 2001 Mar 1;62(1):97-104.

PMID:
11173173
14.

Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study.

Gerra G, Leonardi C, D'Amore A, Strepparola G, Fagetti R, Assi C, Zaimovic A, Lucchini A.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Mar;30(2):265-72. Epub 2005 Nov 23.

PMID:
16309810
15.

Naltrexone and buprenorphine combination in the treatment of opioid dependence.

Gerra G, Fantoma A, Zaimovic A.

J Psychopharmacol. 2006 Nov;20(6):806-14. Epub 2006 Jan 9.

PMID:
16401652
16.

A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial.

Gibson AE, Doran CM, Bell JR, Ryan A, Lintzeris N.

Med J Aust. 2003 Jul 7;179(1):38-42.

PMID:
12831383
17.
18.

Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.

Gerra G, Borella F, Zaimovic A, Moi G, Bussandri M, Bubici C, Bertacca S.

Drug Alcohol Depend. 2004 Jul 15;75(1):37-45.

PMID:
15225887
19.

One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).

Teesson M, Ross J, Darke S, Lynskey M, Ali R, Ritter A, Cooke R.

Drug Alcohol Depend. 2006 Jun 28;83(2):174-80. Epub 2005 Dec 15.

PMID:
16343809
20.

Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.

Schottenfeld RS, Chawarski MC, Mazlan M.

Lancet. 2008 Jun 28;371(9631):2192-200. doi: 10.1016/S0140-6736(08)60954-X.

Supplemental Content

Support Center